TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 31677042

Group type: EXPERIMENTAL
Intervention: Classic Ketogenic Diet (KD)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Modified Atkins Diet (MAD)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Comparison of KD and MAD
Number of subjects: 45
Study: 31480601

Group type: EXPERIMENTAL
Intervention: Pregabalin (oral solution of pregabalin 150 mg twice daily for 14 days)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Placebo solution
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Pregabalin
Number of subjects: 43

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43
Study: 27876198

Group type: EXPERIMENTAL
Intervention: Monovalent rotavirus vaccine (RV1)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pentavalent rotavirus vaccine (RV5)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 0
Study: 26410675

Group type: EXPERIMENTAL
Intervention: Resilience Training (RT)
Number of subjects: 40
Study: 23243253

Group type: COMPARATOR
Intervention: 0% corn DDGS
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: 17% corn DDGS
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: 35% corn DDGS
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: 50% corn DDGS
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: All DDGS diets
Number of subjects: 240
Study: 20152998

Group type: EXPERIMENTAL
Intervention: Metformin + GLP-1
Number of subjects: 10

Group type: COMPARATOR
Intervention: GLP-1
Number of subjects: 10

Group type: COMPARATOR
Intervention: Metformin
Number of subjects: 10
Study: 19239577

Group type: EXPERIMENTAL
Intervention: Sham acupuncture device
Number of subjects: 119

Group type: COMPARATOR
Intervention: Placebo pill
Number of subjects: 119
Study: 17043639

Group type: EXPERIMENTAL
Intervention: 70-gene prognosis predictor (PP) based on non-neoplastic mucosa microarray gene expression
Number of subjects: 24
Study: 15487440

Group type: EXPERIMENTAL
Intervention: Probe recognition paradigm with a memory set of three pure tones followed by a probe tone.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Suffix sound presented 1 second after the third sound in the memory set.
Number of subjects: 0
Study: 11371279

Group type: EXPERIMENTAL
Intervention: MIDCAB with LITA to LAD
Number of subjects: 8
Study: 9244203

Group type: EXPERIMENTAL
Intervention: Azithromycin (500 mg/d for 3 days or 500 mg/d for 6 days)
Number of subjects: 213

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 213

Group type: COMPARATOR
Intervention: Not applicable (Cp+ve-NR group)
Number of subjects: 213

Group type: EXPERIMENTAL
Intervention: Azithromycin
Number of subjects: 213
Study: 8310466

Group type: EXPERIMENTAL
Intervention: Long-term outpatient treatment in alcoholics with previous suicidal behavior
Number of subjects: 72
Study: 2939574

Group type: EXPERIMENTAL
Intervention: Atracurium 0.3 mg/kg
Number of subjects: 46

Group type: COMPARATOR
Intervention: Alcuronium 0.25 mg/kg
Number of subjects: 46
Study: 30202946

Group type: EXPERIMENTAL
Intervention: Omega-3 fish oil
Number of subjects: 289

Group type: EXPERIMENTAL
Intervention: Losartan
Number of subjects: 289

Group type: EXPERIMENTAL
Intervention: Combination of omega-3 and losartan
Number of subjects: 289
Study: 28801396

Group type: EXPERIMENTAL
Intervention: Adjustable anchored single-incision mini-slings (SIMS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard tension-free midurethral slings (SMUS)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Not specified
Number of subjects: 0
Study: 25735918

Group type: EXPERIMENTAL
Intervention: Bemfola (150 IU daily)
Number of subjects: 372

Group type: COMPARATOR
Intervention: Gonal-f (150 IU daily)
Number of subjects: 372

Group type: EXPERIMENTAL
Intervention: Bemfola
Number of subjects: 372

Group type: COMPARATOR
Intervention: Gonal-f
Number of subjects: 372
Study: 23967725

Group type: EXPERIMENTAL
Intervention: Capecitabine monotherapy
Number of subjects: 1

Group type: COMPARATOR
Intervention: Capecitabine conjugated with a new biological agent
Number of subjects: 1
Study: 21700245

Group type: EXPERIMENTAL
Intervention: Facilitated PCI using tenecteplase (Group A)
Number of subjects: 162

Group type: COMPARATOR
Intervention: Primary PCI (Group B)
Number of subjects: 162
Study: 19332456

Group type: EXPERIMENTAL
Intervention: Rosuvastatin 10 mg daily
Number of subjects: 2776

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2776
Study: 16733692

Group type: EXPERIMENTAL
Intervention: Erb:YAG goniotomy
Number of subjects: 40

Group type: COMPARATOR
Intervention: Trabeculectomy
Number of subjects: 40
Study: 15536856

Group type: EXPERIMENTAL
Intervention: C-Fill MH (Megadenta)
Number of subjects: 134

Group type: COMPARATOR
Intervention: Helio Progress (Vivadent)
Number of subjects: 134

Group type: COMPARATOR
Intervention: Visio-Dispers (ESPE)
Number of subjects: 134
Study: 11265901

Group type: EXPERIMENTAL
Intervention: Brochure plus a children's book
Number of subjects: 43

Group type: COMPARATOR
Intervention: Brochure alone
Number of subjects: 43
Study: 9631846

Group type: EXPERIMENTAL
Intervention: Polymethylmethacrylate (PMMA) membrane
Number of subjects: 16

Group type: COMPARATOR
Intervention: Cuprophane membrane
Number of subjects: 16
Study: 3068160

Group type: EXPERIMENTAL
Intervention: Piroxicam (20 mg) + Rosaprostol (2 g) daily
Number of subjects: 44

Group type: COMPARATOR
Intervention: Piroxicam (20 mg) + Placebo
Number of subjects: 44

Group type: COMPARATOR
Intervention: NSAIDs (diclofenac sodium 50 mg, piroxicam 20 mg, acetylsalicylic acid 500 mg)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Rosaprostol (2 g)
Number of subjects: 44
Study: 31385912

Group type: EXPERIMENTAL
Intervention: Moderate-intensity aerobic exercise
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Light-intensity aerobic exercise
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Aerobic training intervention (12 weeks)
Number of subjects: 34
Study: 28937272

Group type: EXPERIMENTAL
Intervention: Movement music therapy (MMT) group, 35 participants
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control STT group, 10 participants
Number of subjects: 45
Study: 27627596

Group type: EXPERIMENTAL
Intervention: Antimicrobial mouthrinse (alcohol-free mouthrinse containing 0.7% cetylpyridinium chloride)
Number of subjects: 466

Group type: COMPARATOR
Intervention: Control group (oral hygiene education only)
Number of subjects: 466
Study: 26308827

Group type: EXPERIMENTAL
Intervention: 12 seconds of interrepetition rest (IRR12)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: 6 seconds of interrepetition rest (IRR6)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Continuous repetitions (CR)
Number of subjects: 34
Study: 23362019

Group type: EXPERIMENTAL
Intervention: Cryoballoon catheter
Number of subjects: 30

Group type: COMPARATOR
Intervention: RF energy-based pulmonary vein ablation catheter (PVAC)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Both groups (Cryoballoon and PVAC)
Number of subjects: 30
Study: 21599573

Group type: EXPERIMENTAL
Intervention: 150 ml of red wine/day for women (16 g ethanol/day) or 300 ml of red wine/day for men (33 g ethanol/day)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Alcohol abstention for 90 days
Number of subjects: 44
Study: 18528650

Group type: EXPERIMENTAL
Intervention: Heat/steam-generating sheet
Number of subjects: 37

Group type: COMPARATOR
Intervention: Dry heat-generating sheet
Number of subjects: 37
Study: 16766434

Group type: EXPERIMENTAL
Intervention: Conjugated estrogens/medroxyprogesterone acetate (CE/MPA) doses: 0.625/2.5, 0.45/1.5, or 0.3/1.5 mg daily for 24 weeks
Number of subjects: 1028
Study: 12959796

Group type: EXPERIMENTAL
Intervention: Proactive recruitment strategies (in-person appeals by study staff and health care providers)
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Reactive recruitment strategies (disseminating information that asked people to call a study hotline)
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Cost of recruitment
Number of subjects: 600
Study: 10862930

Group type: EXPERIMENTAL
Intervention: Native /ba/‐/da/ contrasts
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hindi dental /da/‐retroflex /da/ contrasts
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Within‐category /ba/‐/ba/ contrasts
Number of subjects: 0
Study: 8904521

Group type: EXPERIMENTAL
Intervention: Recombinant human erythropoietin (rhEPO) 300 U kg‐1, i.v. or s.c., once, combined with parenteral and oral iron
Number of subjects: 90

Group type: COMPARATOR
Intervention: Iron therapy only
Number of subjects: 90
Study: 2125737

Group type: EXPERIMENTAL
Intervention: Lithium carbonate (mean daily dose of 587 +/- 49 mg)
Number of subjects: 10
Study: 6998597

Group type: EXPERIMENTAL
Intervention: 30 mg/kg of methylprednisolone sodium succinate (MPN)
Number of subjects: 28

Group type: COMPARATOR
Intervention: 15 mg/kg of mannitol placebo (PL)
Number of subjects: 28
Study: 31585794

Group type: EXPERIMENTAL
Intervention: Close Reading and Creative Writing program
Number of subjects: 49

Group type: COMPARATOR
Intervention: Classical structured educational approach
Number of subjects: 49
Study: 31056884

Group type: EXPERIMENTAL
Intervention: Shallow acupuncture combined with ear-acupoint pellet-pressing
Number of subjects: 60

Group type: COMPARATOR
Intervention: Oral Alprazolam tablets once a day
Number of subjects: 60
Study: 28356271

Group type: EXPERIMENTAL
Intervention: Cashew diet (28-64 g/d)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Potato chips (control)
Number of subjects: 51
Study: 25308927

Group type: EXPERIMENTAL
Intervention: TF+YF+MenACWY-CRM (group I)
Number of subjects: 301

Group type: COMPARATOR
Intervention: TF+YF (group II)
Number of subjects: 301

Group type: COMPARATOR
Intervention: MenACWY-CRM (group III)
Number of subjects: 301
Study: 23911536

Group type: EXPERIMENTAL
Intervention: Intensive glucose management
Number of subjects: 740

Group type: COMPARATOR
Intervention: Standard glucose management
Number of subjects: 740
Study: 21736808

Group type: EXPERIMENTAL
Intervention: Dried plum (100 g/d)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Dried apple (comparative control)
Number of subjects: 160
Study: 19402851

Group type: EXPERIMENTAL
Intervention: Short waiting time (WT) group (n = 174)
Number of subjects: 395

Group type: COMPARATOR
Intervention: Nonfixed waiting time group (n = 221)
Number of subjects: 395
Study: 16492822

Group type: EXPERIMENTAL
Intervention: Continuous epidural block (CEB)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Continuous popliteal nerve block (CPNB)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Both CEB and CPNB
Number of subjects: 52
Study: 12723104

Group type: EXPERIMENTAL
Intervention: Chewing gum containing pyrophosphate (1%) and tripolyphosphate (1%)
Number of subjects: 117

Group type: COMPARATOR
Intervention: No gum
Number of subjects: 117
Study: 11054780

Group type: EXPERIMENTAL
Intervention: Cognitive-behavior therapy (CBT)
Number of subjects: 98
Study: 9228589

Group type: EXPERIMENTAL
Intervention: Condoms meeting Australian and ISO standards
Number of subjects: 92

Group type: COMPARATOR
Intervention: Condoms meeting Swiss Quality Seal requirements
Number of subjects: 92
Study: 7956622

Group type: EXPERIMENTAL
Intervention: Daytime insulin infusion (mean 1.5 +/- 0.1 IU/h)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Nocturnal insulin infusion (mean 1.5 +/- 0.1 IU/h)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Nocturnal insulin infusion
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Daytime insulin infusion
Number of subjects: 20
Study: 3597264

Group type: EXPERIMENTAL
Intervention: Inspiratory resistive loads (8.9‐35.7 cmH2O X l‐1 X s)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control condition (no specific details provided)
Number of subjects: 0
Study: 28738711

Group type: EXPERIMENTAL
Intervention: Kangaroo ward care (KWC)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Intermediate intensive care (IIC)
Number of subjects: 79
Study: 27759857

Group type: EXPERIMENTAL
Intervention: Topical squalamine and intravitreal ranibizumab 0.5 mg
Number of subjects: 20

Group type: COMPARATOR
Intervention: Ranibizumab 0.5 mg (control)
Number of subjects: 20
Study: 25045235

Group type: EXPERIMENTAL
Intervention: Intravenous ketamine infusion during general anesthesia
Number of subjects: 40

Group type: COMPARATOR
Intervention: Normal saline equivalent to ketamine infusions
Number of subjects: 40
Study: 22513081

Group type: EXPERIMENTAL
Intervention: Levocetirizine plus Lactobacillus johnsonii EM1 (Lj EM1)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Levocetirizine alone
Number of subjects: 63
Study: 20930161

Group type: EXPERIMENTAL
Intervention: Low-molecular weight heparin
Number of subjects: 119

Group type: COMPARATOR
Intervention: Unfractionated heparin
Number of subjects: 119
Study: 18215561

Group type: EXPERIMENTAL
Intervention: Booster seat promotion program in low-income community
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Booster seat promotion program in Hispanic community
Number of subjects: 0

Group type: COMPARATOR
Intervention: Comparison communities (control)
Number of subjects: 0
Study: 16154441

Group type: COMPARATOR
Intervention: High-carbohydrate diet (CHO, 58%; fat, 26%; n = 23)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: High-monounsaturated fatty acid diet (high MUFA, CHO 45%; fat 40%; MUFA 22.5%; n = 24)
Number of subjects: 47

Group type: COMPARATOR
Intervention: High-carbohydrate diet (CHO)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: High-monounsaturated fatty acid diet (high MUFA)
Number of subjects: 47
Study: 15259481

Group type: EXPERIMENTAL
Intervention: 2 doses of 10 mg/kg triclabendazole
Number of subjects: 154

Group type: COMPARATOR
Intervention: Single dose of 10 mg/kg triclabendazole
Number of subjects: 154
Study: 10223765

Group type: EXPERIMENTAL
Intervention: Preoperative radiotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Postoperative radiotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combined adjuvant chemotherapy and radiotherapy
Number of subjects: 0
Study: 8964406

Group type: EXPERIMENTAL
Intervention: Fluconazole
Number of subjects: 134

Group type: COMPARATOR
Intervention: Endoscopy
Number of subjects: 134
Study: 1403921

Group type: EXPERIMENTAL
Intervention: 3 mm access preparations wetted with mercury-rich amalgam before restoration
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: 3 mm access preparations restored unwetted
Number of subjects: 72

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 72
Study: 3886191

Group type: EXPERIMENTAL
Intervention: Amrinone (1.5 mg/kg tid increasing to a maximum dosage of 200 mg tid)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Amrinone
Number of subjects: 99
Study: 30053060

Group type: EXPERIMENTAL
Intervention: Asthma Action Plan (AAP) with standard care
Number of subjects: 320

Group type: COMPARATOR
Intervention: Routine standard of care (Control)
Number of subjects: 320
Study: 26911981

Group type: EXPERIMENTAL
Intervention: Physical Therapy (PT)
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Lidocaine Injections (LI)
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Combination of Physical Therapy and Lidocaine Injections (PT + LI)
Number of subjects: 127
Study: 24468797

Group type: EXPERIMENTAL
Intervention: Elastic girdle
Number of subjects: 48

Group type: COMPARATOR
Intervention: No girdle (Control)
Number of subjects: 48
Study: 22629839

Group type: EXPERIMENTAL
Intervention: Reamberin
Number of subjects: 89

Group type: COMPARATOR
Intervention: Control
Number of subjects: 89
Study: 20173440

Group type: EXPERIMENTAL
Intervention: Miniscalpel-needle (MSN) release in conjunction with self neck-stretching exercises
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Acupuncture needling treatment and self neck-stretching exercises
Number of subjects: 43

Group type: COMPARATOR
Intervention: Self neck-stretching exercises only
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Miniscalpel-needle (MSN) release
Number of subjects: 43
Study: 18243639

Group type: EXPERIMENTAL
Intervention: Subcutaneous tetrodotoxin administered over Days 1-4
Number of subjects: 82

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Subcutaneous tetrodotoxin
Number of subjects: 82
Study: 16012279

Group type: EXPERIMENTAL
Intervention: rTMS applied for 10 consecutive weekdays, for 15 minutes at 1 Hz and 90% of the resting motor threshold
Number of subjects: 33

Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 33
Study: 12898503

Group type: EXPERIMENTAL
Intervention: Outpatient commitment (OPC)
Number of subjects: 0
Study: 10397520

Group type: EXPERIMENTAL
Intervention: One stage full-mouth disinfection treatment
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard therapy (scaling and root planing per quadrant at 2-week intervals)
Number of subjects: 40
Study: 8655981

Group type: EXPERIMENTAL
Intervention: Nitric oxide (NO) treatment
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control group (30 controls)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 35
Study: 1515957

Group type: EXPERIMENTAL
Intervention: Nitroglycerin (NTG) 6 micrograms.kg‐1.min‐1
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Nicardipine (NICAR) 10 micrograms.kg‐1.min‐1 over 10 minutes followed by an infusion at 4 mg.kg‐1.min‐1
Number of subjects: 37
Study: 7124431

Group type: EXPERIMENTAL
Intervention: Motipress (combined anxiolytic/antidepressant)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 31689640

Group type: EXPERIMENTAL
Intervention: Brief Motivational Intervention (BMI)
Number of subjects: 324

Group type: EXPERIMENTAL
Intervention: BMI with a telephone booster (BMI + B)
Number of subjects: 324

Group type: COMPARATOR
Intervention: Brief Advice (BA)
Number of subjects: 324
Study: 28318407

Group type: EXPERIMENTAL
Intervention: Custom-mold room temperature vulcanizing silicone toe separator for 6 hours per night for 12 months
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 90
Study: 27476789

Group type: EXPERIMENTAL
Intervention: Edoxaban 60 mg once per day (or 30 mg once per day for specific patients)
Number of subjects: 771

Group type: COMPARATOR
Intervention: Warfarin (dose adjusted to maintain INR between 2.0 and 3.0)
Number of subjects: 771

Group type: EXPERIMENTAL
Intervention: Edoxaban
Number of subjects: 771

Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 771
Study: 25181622

Group type: EXPERIMENTAL
Intervention: Rectally administrated 800 mg misoprostol
Number of subjects: 192

Group type: COMPARATOR
Intervention: Intravenous oxytocin infusion
Number of subjects: 192
Study: 22248028

Group type: EXPERIMENTAL
Intervention: β‐elemene at 45 mg/kg
Number of subjects: 0
Study: 19693500

Group type: EXPERIMENTAL
Intervention: Dose-dense therapy (CEOP/IMVP-Dexa)
Number of subjects: 115

Group type: COMPARATOR
Intervention: Standard therapy (CHOP)
Number of subjects: 115
Study: 18584415

Group type: EXPERIMENTAL
Intervention: E(2) 2 mg/day plus medroxyprogesterone acetate (MPA) 2.5 mg/day
Number of subjects: 125

Group type: COMPARATOR
Intervention: E(2) 2 mg/day
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: E(2) 2 mg/day plus dienogest 2 mg/day
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: E(2) 2 mg/day plus norethisterone acetate (NETA) 1 mg/day
Number of subjects: 125
Study: 16198422

Group type: EXPERIMENTAL
Intervention: Amniotic membrane transplantation (AMT)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Conventional medical therapy
Number of subjects: 37
Study: 12174408

Group type: EXPERIMENTAL
Intervention: Intervention strategy including direct letters to patients
Number of subjects: 29

Group type: COMPARATOR
Intervention: Two interventions that did not include direct patient letters
Number of subjects: 29
Study: 10206086

Group type: COMPARATOR
Intervention: Nisoldipine 5 mg alone
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Nisoldipine 5 mg with ketoconazole 200 mg (4 days pretreatment and concomitant administration)
Number of subjects: 7
Study: 7842185

Group type: EXPERIMENTAL
Intervention: Ipratropium bromide (80 micrograms)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 2696323

Group type: EXPERIMENTAL
Intervention: Postoperative doxorubicin
Number of subjects: 240

Group type: COMPARATOR
Intervention: Control (no doxorubicin)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Compartmental or wide amputation
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Compartmental local excision
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Wide local excision
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Marginal excision and radiotherapy
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Marginal excision alone (reevaluated margin)
Number of subjects: 240
Study: 31955164

Group type: EXPERIMENTAL
Intervention: 25-gauge illumination-aided scleral buckling (SB) combined with hyaluronate injection after subretinal fluid drainage.
Number of subjects: 45

Group type: COMPARATOR
Intervention: Conventional SB with binocular indirect ophthalmoscope combined with air injection.
Number of subjects: 45
Study: 30865795

Group type: EXPERIMENTAL
Intervention: Antibiotics (400 mg oral doxycycline and 400 mg oral metronidazole)
Number of subjects: 3412

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3412
Study: 28338503

Group type: EXPERIMENTAL
Intervention: Crystalline valsartan/sacubitril (LCZ696) 400 mg daily
Number of subjects: 907

Group type: COMPARATOR
Intervention: Valsartan 320 mg daily
Number of subjects: 907

Group type: EXPERIMENTAL
Intervention: Combination of free valsartan 320 mg and sacubitril 200 mg
Number of subjects: 907

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 907
Study: 25464158

Group type: EXPERIMENTAL
Intervention: Noxious conditioning stimulus (CS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-noxious (sham) conditioning stimulus (CS)
Number of subjects: 0
Study: 23871265

Group type: EXPERIMENTAL
Intervention: Ketoprofen (3mg/kg) administered intramuscularly for 3 days p.p.
Number of subjects: 20
Study: 21282280

Group type: EXPERIMENTAL
Intervention: Rivastigmine patch (9.5 mg/24 hours)
Number of subjects: 892

Group type: EXPERIMENTAL
Intervention: Rivastigmine capsules (6 mg twice daily)
Number of subjects: 892
Study: 18463427

Group type: EXPERIMENTAL
Intervention: Garlic (0.1 g/kg b.w. daily for 1 month)
Number of subjects: 13
Study: 16415635

Group type: EXPERIMENTAL
Intervention: Intensive antihypertensive therapy using fixed-dose combinations of two antihypertensive agents.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard antihypertensive therapy (implied control group).
Number of subjects: 0